SpringWorks Therapeutics Inc. (SWTX) – Analyst Comments
-
Spring Works Therapeutics (SWTX) PT Raised to $52 at Goldman Sachs
-
BofA Securities Starts Spring Works Therapeutics (SWTX) at Buy on Rare Tumor Drug Differentiator
-
-
-
-
-
-
-
Back to SWTX Stock Lookup